+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Genome Editing Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon


  • 193 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5754712
The Global Genome Editing Market is estimated to be USD 8.54 Bn in 2023 and is expected to reach USD 24.13 Bn by 2028 growing at a CAGR of 23.1%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Genome Editing Market is segmented based on Product & Servies, Technolgy, Application, End User, and Geography.
  • By Product & Services, the market is classified into Software & Systems, Services, and Reagents & Consumables.
  • >By Technology, the market is classified into ZFN, TALEN, CRISPR, Antisense, and Other Technologies.
  • >By Application, the market is classified into Animal Genetic Engineering, Plant Genetic Engineering, Drug Discovery and Development, Diagnostic applications, Cell Line Engineering, and Other Applications.
  • By End User, the market is classified into pharmaceutical companies, Government Research Institutes, Biotechnology companies, and Academic Research Institutes.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Beren Therapeutics, Agilent Technologies, Creative Biogene, Intellia Therapeutics, Horizon Discovery Group PLC., Tecan Life-Sciences, Synthego, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Genome Editing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Genome Editing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Genome Editing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rise in Production of Genetically Modified Crops
4.1.2 Increasing Government Funding and Growth in the Number of Genomics Projects
4.1.3 Introduction of CRISPR-Cas9
4.1.4 Increased Applications Areas of Genomics
4.1.5 High Prevalence of Infectious Diseases and Cancer
4.2 Restraints
4.2.1 High Cost of Genomic Equipment
4.2.2 Ethical Concerns Related to Genetic Research
4.2.3 Limited Availability of Trained Professionals
4.2.4 Adverse Public Perception of Genetic Research
4.3 Opportunities
4.3.1 Presence of Key Players in Emerging Economics and Application in Several Drug Discovery Processes
4.3.2 Increasing Use of Genome Editing in Specialized Medicine
4.3.3 Advancements in Genome Editing with CRISPR-Cas9 System
4.4 Challenges
4.4.1 Secure Storage of Large Volumes of Sequenced Data
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTEL Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Genome Editing Market, By Product & Services
6.1 Introduction
6.2 Software & Systems
6.3 Services
6.4 Reagents & Consumables
7 Global Genome Editing Market, By Technology
7.1 Introduction
7.2 ZFN
7.5 Antisense
7.6 Other Technologies
8 Global Genome Editing Market, By Application
8.1 Introduction
8.2 Animal Genetic Engineering
8.3 Plant Genetic Engineering
8.4 Drug Discovery and Development
8.5 Diagnostic applications
8.6 Cell Line Engineering
8.7 Other Applications
9 Global Genome Editing Market, By End User
9.1 Introduction
9.2 Pharmaceutical companies
9.3 Government Research Institutes
9.4 Biotechnology companies
9.5 Academic Research Institutes
10 Americas' Genome Editing Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's Genome Editing Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa's Genome Editing Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC's Genome Editing Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 Agilent Technologies
15.2 Bean Therapeutics
15.3 Beren Therapeutics
15.4 Bluebird Bio
15.5 Creative Biogene
15.6 Editas Medicine
15.7 GenScript USA, Inc.
15.8 Horizon Discovery Group PLC
15.9 Integrated DNA Technologies, Inc.
15.10 Intellia Therapeutics
15.11 Lonza Group Ltd
15.12 Merck & Co.
15.13 New England Biolabs, Inc.
15.14 Origene Technologies, Inc.
15.15 Sangamo Biosciences, Inc.
15.16 Synthego
15.17 Takara Bio Inc.
15.18 Tecan Life-Sciences
15.19 Thermo Fisher Scientific, Inc.
15.20 Transposagen Biopharmaceuticals, Inc.
16 Appendix
16.1 Questionnaire

Companies Mentioned

  • Agilent Technologies
  • Bean Therapeutics
  • Beren Therapeutics
  • Bluebird Bio
  • Creative Biogene
  • Editas Medicine
  • GenScript USA, Inc.
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics
  • Lonza Group Ltd
  • Merck & Co.
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Sangamo Biosciences, Inc.
  • Synthego
  • Takara Bio Inc.
  • Tecan Life-Sciences
  • Thermo Fisher Scientific, Inc.
  • Transposagen Biopharmaceuticals, Inc.